Emergency appeal on abortion pills

Danco Laboratories has filed an emergency petition with the U.S. Supreme Court seeking to preserve the mail-order distribution of the abortion pill mifepristone.

The appeal follows a lower court ruling that reinstated restrictive in-person prescription requirements, effectively banning telehealth access to the drug.

The manufacturer warned that the ruling would cause immediate 'healthcare chaos' and significantly impede access for millions of women.

This case marks the latest high-stakes legal battle over reproductive rights to reach the nation's highest court since the overturning of Roe v.

Wade.